PyrAmes
PyrAmes has developed a paper thin, flexible, ultra low power device for non-invasive monitoring of blood pressure.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor investor investor investor | €0.0 | round |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
$6.0m | Series A | ||
| Total Funding | 000k | ||
Related Content
PyrAmes is a digital health company dedicated to revolutionizing healthcare delivery through continuous, non-invasive blood pressure monitoring. The company's core product, Boppli, has received FDA Breakthrough Device Designation and 510k market clearance, underscoring its innovative approach. PyrAmes serves a diverse clientele, including newborns, seniors, and individuals with hypertension, offering a comfortable and easy-to-use platform that enhances blood pressure management. Operating in the healthcare technology market, PyrAmes generates revenue through the sale of its advanced blood pressure monitoring devices, which utilize cutting-edge sensors for continuous non-invasive blood pressure (cNIBP) measurement. The company engages with physicians, medical personnel, researchers, inventors, investors, and potential users to further develop and refine its technology. PyrAmes' business model focuses on providing accurate, wireless, and non-invasive solutions that improve patient outcomes and streamline healthcare processes.
Keywords: digital health, blood pressure monitoring, non-invasive, wireless, continuous monitoring, FDA clearance, hypertension, healthcare technology, sensors, patient care.